Cumberland Pharmaceuticals (CPIX) Competitors $2.25 -0.02 (-0.88%) (As of 12:07 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CPIX vs. ASMB, LLY, JNJ, ABBV, MRK, PFE, BMY, ZTS, RPRX, and JAZZShould you be buying Cumberland Pharmaceuticals stock or one of its competitors? The main competitors of Cumberland Pharmaceuticals include Assembly Biosciences (ASMB), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), and Jazz Pharmaceuticals (JAZZ). These companies are all part of the "pharmaceuticals" industry. Cumberland Pharmaceuticals vs. Assembly Biosciences Eli Lilly and Company Johnson & Johnson AbbVie Merck & Co., Inc. Pfizer Bristol-Myers Squibb Zoetis Royalty Pharma Jazz Pharmaceuticals Assembly Biosciences (NASDAQ:ASMB) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings. Does the MarketBeat Community believe in ASMB or CPIX? Assembly Biosciences received 56 more outperform votes than Cumberland Pharmaceuticals when rated by MarketBeat users. Likewise, 58.98% of users gave Assembly Biosciences an outperform vote while only 42.21% of users gave Cumberland Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAssembly BiosciencesOutperform Votes24358.98% Underperform Votes16941.02% Cumberland PharmaceuticalsOutperform Votes18742.21% Underperform Votes25657.79% Do insiders and institutionals hold more shares of ASMB or CPIX? 19.9% of Assembly Biosciences shares are owned by institutional investors. Comparatively, 15.5% of Cumberland Pharmaceuticals shares are owned by institutional investors. 5.1% of Assembly Biosciences shares are owned by insiders. Comparatively, 43.3% of Cumberland Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is ASMB or CPIX more profitable? Cumberland Pharmaceuticals has a net margin of -29.54% compared to Assembly Biosciences' net margin of -144.05%. Cumberland Pharmaceuticals' return on equity of -9.50% beat Assembly Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Assembly Biosciences-144.05% -121.46% -34.56% Cumberland Pharmaceuticals -29.54%-9.50%-3.19% Which has stronger earnings and valuation, ASMB or CPIX? Cumberland Pharmaceuticals has higher revenue and earnings than Assembly Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAssembly Biosciences$28.33M3.42-$61.23MN/AN/ACumberland Pharmaceuticals$36.79M0.86-$6.28M-$0.77-2.94 Which has more risk and volatility, ASMB or CPIX? Assembly Biosciences has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Cumberland Pharmaceuticals has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500. Does the media prefer ASMB or CPIX? In the previous week, Assembly Biosciences and Assembly Biosciences both had 5 articles in the media. Assembly Biosciences' average media sentiment score of 0.21 beat Cumberland Pharmaceuticals' score of -0.29 indicating that Assembly Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Assembly Biosciences 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cumberland Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Do analysts prefer ASMB or CPIX? Assembly Biosciences currently has a consensus price target of $35.00, suggesting a potential upside of 129.96%. Given Assembly Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Assembly Biosciences is more favorable than Cumberland Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Assembly Biosciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Cumberland Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAssembly Biosciences beats Cumberland Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Ad Insiders ExposedNo one’s talking about these Trump tradesAs you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get Cumberland Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPIX vs. The Competition Export to ExcelMetricCumberland PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.74M$6.61B$5.16B$9.10BDividend YieldN/A2.99%5.12%4.26%P/E Ratio-2.9410.6387.5117.12Price / Sales0.86194.281,136.45119.65Price / Cash3.5057.1643.2337.85Price / Book1.155.104.784.77Net Income-$6.28M$151.83M$120.55M$225.50M7 Day Performance6.60%-1.19%-1.64%-1.29%1 Month Performance113.21%-4.73%14.04%0.45%1 Year Performance29.89%8.89%28.88%15.38% Cumberland Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPIXCumberland Pharmaceuticals0.3334 of 5 stars$2.26-0.4%N/A+30.5%$31.74M$36.79M-2.9480Analyst ForecastGap DownASMBAssembly Biosciences3.8084 of 5 stars$15.50+0.8%$35.00+125.8%+60.4%$98.52M$28.33M0.00100Gap DownLLYEli Lilly and Company4.9941 of 5 stars$779.34-1.2%$1,002.22+28.6%+34.6%$739.84B$40.86B85.4843,000JNJJohnson & Johnson4.8583 of 5 stars$145.04-1.1%$174.73+20.5%-7.1%$349.20B$87.70B21.22131,900ABBVAbbVie4.9421 of 5 stars$172.71-0.4%$203.65+17.9%+13.3%$305.20B$55.53B60.2350,000MRKMerck & Co., Inc.4.9874 of 5 stars$100.98-0.2%$129.20+27.9%-9.0%$255.44B$60.12B21.3172,000Analyst DowngradePFEPfizer4.9674 of 5 stars$25.48-0.4%$32.15+26.2%-7.2%$144.39B$58.50B34.7688,000Options VolumeAnalyst RevisionBMYBristol-Myers Squibb4.7522 of 5 stars$56.20+0.8%$55.64-1.0%+9.6%$113.98B$47.44B-15.5434,100ZTSZoetis4.589 of 5 stars$177.76-0.2%$216.70+21.9%-15.5%$80.20B$8.54B33.4914,100RPRXRoyalty Pharma4.5927 of 5 stars$25.11+1.1%$41.67+65.9%-9.5%$14.79B$2.36B12.8780Positive NewsJAZZJazz Pharmaceuticals4.8627 of 5 stars$125.00+1.6%$177.00+41.6%+1.4%$7.56B$3.99B17.332,800 Related Companies and Tools Related Companies ASMB Alternatives LLY Alternatives JNJ Alternatives ABBV Alternatives MRK Alternatives PFE Alternatives BMY Alternatives ZTS Alternatives RPRX Alternatives JAZZ Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CPIX) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
